Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Biondi A, Gandemer V, De Lorenzo P, Cario G, Campbell M, Castor A, Pieters R, Baruchel A, Vora A, Leoni V, Stary J, Escherich G, Li CK, Cazzaniga G, Cavé H, Bradtke J, Conter V, Saha V, Schrappe M, Grazia Valsecchi M.

Lancet Haematol. 2018 Dec;5(12):e641-e652. doi: 10.1016/S2352-3026(18)30173-X.

PMID:
30501871
2.

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.

Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M.

Haematologica. 2019 Jan;104(1):e13-e16. doi: 10.3324/haematol.2018.199422. Epub 2018 Sep 13. No abstract available.

3.

Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.

Olsson L, Lundin-Ström KB, Castor A, Behrendtz M, Biloglav A, Norén-Nyström U, Paulsson K, Johansson B.

Genes Chromosomes Cancer. 2018 Nov;57(11):604-607. doi: 10.1002/gcc.22664. Epub 2018 Sep 11.

PMID:
30203896
4.

Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia.

Lundin-Ström KB, Biloglav A, Lilljebjörn H, Rissler M, Fioretos T, Hansson M, Behrendtz M, Castor A, Olsson L, Johansson B.

Leukemia. 2018 Sep;32(9):2058-2062. doi: 10.1038/s41375-018-0191-0. Epub 2018 Jul 2. No abstract available.

5.

Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia.

Gunnarsson R, Dilorenzo S, Lundin-Ström KB, Olsson L, Biloglav A, Lilljebjörn H, Rissler M, Wahlberg P, Lundmark A, Castor A, Behrendtz M, Fioretos T, Paulsson K, Isaksson A, Johansson B.

Leukemia. 2018 Oct;32(10):2117-2125. doi: 10.1038/s41375-018-0092-2. Epub 2018 Mar 12.

6.

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.

Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, van der Velden V, Stary J, Zuna J, Escherich G, Stadt UZ, Aricò M, Conter V, Schrappe M, Valsecchi MG, Biondi A.

Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.

7.

Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.

Mogensen SS, Harila-Saari A, Frandsen TL, Lähteenmäki P, Castor A, Kohonen I, Schmiegelow K, Mäkitie O.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26624. Epub 2017 May 18.

PMID:
28521072
8.

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S, Askmyr M, Rissler M, Schrappe M, Cario G, Castor A, Pronk CJ, Behrendtz M, Mitelman F, Johansson B, Paulsson K, Andersson AK, Fontes M, Fioretos T.

Nat Commun. 2016 Jun 6;7:11790. doi: 10.1038/ncomms11790.

9.

The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes.

Olsson L, Zettermark S, Biloglav A, Castor A, Behrendtz M, Forestier E, Paulsson K, Johansson B.

Br J Haematol. 2016 Jul;174(2):292-301. doi: 10.1111/bjh.14056. Epub 2016 Mar 28.

PMID:
27022003
10.

Support from healthcare services during transition to adulthood - Experiences of young adult survivors of pediatric cancer.

Svedberg P, Einberg EL, Wärnestål P, Stigmar J, Castor A, Enskär K, Nygren JM.

Eur J Oncol Nurs. 2016 Apr;21:105-12. doi: 10.1016/j.ejon.2016.02.008. Epub 2016 Feb 23.

PMID:
26952685
11.

Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.

Tulstrup M, Larsen HB, Castor A, Rossel P, Grell K, Heyman M, Abrahamsson J, Söderhäll S, Åsberg A, Jonsson OG, Vettenranta K, Frandsen TL, Albertsen BK, Schmiegelow K; Nordic Society of Paediatric Haematology, and Oncology (NOPHO).

Pediatr Blood Cancer. 2016 May;63(5):865-71. doi: 10.1002/pbc.25887. Epub 2015 Dec 31.

PMID:
26717887
12.

Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

Safavi S, Olsson L, Biloglav A, Veerla S, Blendberg M, Tayebwa J, Behrendtz M, Castor A, Hansson M, Johansson B, Paulsson K.

Oncotarget. 2015 Dec 15;6(40):42793-802. doi: 10.18632/oncotarget.6000.

13.

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.

Marincevic-Zuniga Y, Zachariadis V, Cavelier L, Castor A, Barbany G, Forestier E, Fogelstrand L, Heyman M, Abrahamsson J, Lönnerholm G, Nordgren A, Syvänen AC, Nordlund J.

Haematologica. 2016 Jan;101(1):e20-3. doi: 10.3324/haematol.2015.132332. Epub 2015 Oct 22. No abstract available.

14.

The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Paulsson K, Lilljebjörn H, Biloglav A, Olsson L, Rissler M, Castor A, Barbany G, Fogelstrand L, Nordgren A, Sjögren H, Fioretos T, Johansson B.

Nat Genet. 2015 Jun;47(6):672-6. doi: 10.1038/ng.3301. Epub 2015 May 11.

PMID:
25961940
15.

Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.

Karrman K, Castor A, Behrendtz M, Forestier E, Olsson L, Ehinger M, Biloglav A, Fioretos T, Paulsson K, Johansson B.

J Hematol Oncol. 2015 Apr 24;8:42. doi: 10.1186/s13045-015-0138-0.

16.

Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.

Olsson L, Albitar F, Castor A, Behrendtz M, Biloglav A, Paulsson K, Johansson B.

Genes Chromosomes Cancer. 2015 May;54(5):315-25. doi: 10.1002/gcc.22245. Epub 2015 Feb 26.

PMID:
25727050
17.

Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.

Olsson L, Castor A, Behrendtz M, Biloglav A, Forestier E, Paulsson K, Johansson B.

Leukemia. 2014 Feb;28(2):302-10. doi: 10.1038/leu.2013.206. Epub 2013 Jul 4.

PMID:
23823658
18.

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.

Lutz C, Woll PS, Hall G, Castor A, Dreau H, Cazzaniga G, Zuna J, Jensen C, Clark SA, Biondi A, Mitchell C, Ferry H, Schuh A, Buckle V, Jacobsen SW, Enver T.

Leukemia. 2013 Apr;27(5):1204-1207. doi: 10.1038/leu.2012.306. Epub 2012 Oct 22. No abstract available.

19.

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.

Biondi A, Schrappe M, De Lorenzo P, Castor A, Lucchini G, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Li CK, Vora A, Aricò M, Röttgers S, Saha V, Valsecchi MG.

Lancet Oncol. 2012 Sep;13(9):936-45. doi: 10.1016/S1470-2045(12)70377-7. Epub 2012 Aug 14.

20.

Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.

Frandsen TL, Abrahamsson J, Lausen B, Vettenranta K, Heyman M, Behrentz M, Castor A, Wehner PS, Frost BM, Andersen EW, Schmiegelow K.

Br J Haematol. 2011 Oct;155(2):244-7. doi: 10.1111/j.1365-2141.2011.08835.x. Epub 2011 Aug 18.

PMID:
21848519
21.

Volume of prescription opioids used nonmedically in the United States.

Katz NP, Birnbaum HG, Castor A.

J Pain Palliat Care Pharmacother. 2010 Jun;24(2):141-4. doi: 10.3109/15360281003799098.

PMID:
20504136
22.

High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle.

Tipping AJ, Pina C, Castor A, Hong D, Rodrigues NP, Lazzari L, May GE, Jacobsen SE, Enver T.

Blood. 2009 Mar 19;113(12):2661-72. doi: 10.1182/blood-2008-06-161117. Epub 2009 Jan 23.

23.

Exit of pediatric pre-B acute lymphoblastic leukaemia cells from the bone marrow to the peripheral blood is not associated with cell maturation or alterations in gene expression.

Hansson F, Toporski J, Månsson R, Johansson B, Norén-Nyström U, Jacobsen SE, Wiebe T, Larsson M, Sigvardsson M, Castor A.

Mol Cancer. 2008 Aug 11;7:67. doi: 10.1186/1476-4598-7-67.

24.

Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.

Lönnerholm G, Frost BM, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Heyman M, Uges DR, de Graaf SS.

Br J Haematol. 2008 Aug;142(4):616-21. doi: 10.1111/j.1365-2141.2008.07235.x. Epub 2008 Jun 4.

PMID:
18537965
25.

Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis.

Buitenhuis M, Verhagen LP, van Deutekom HW, Castor A, Verploegen S, Koenderman L, Jacobsen SE, Coffer PJ.

Blood. 2008 Jan 1;111(1):112-21. Epub 2007 Sep 21.

26.

Economic burden and co-morbidities of atrial fibrillation in a privately insured population.

Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J.

Curr Med Res Opin. 2005 Oct;21(10):1693-9.

PMID:
16238910
27.

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.

Castor A, Nilsson L, Astrand-Grundström I, Buitenhuis M, Ramirez C, Anderson K, Strömbeck B, Garwicz S, Békássy AN, Schmiegelow K, Lausen B, Hokland P, Lehmann S, Juliusson G, Johansson B, Jacobsen SE.

Nat Med. 2005 Jun;11(6):630-7. Epub 2005 May 22.

PMID:
15908956
28.

Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2.

Buitenhuis M, van Deutekom HW, Verhagen LP, Castor A, Jacobsen SE, Lammers JW, Koenderman L, Coffer PJ.

Blood. 2005 Jun 1;105(11):4272-81. Epub 2005 Feb 8.

29.

How transthoracic echocardiography detects cardiac tamponade.

Shatzer M, Castor A.

Nursing. 2004 Mar;34(3):73-4. No abstract available.

PMID:
15180010
30.

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.

Frost BM, Lönnerholm G, Koopmans P, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Uges DR, de Graaf SS.

Acta Paediatr. 2003 May;92(5):551-7.

PMID:
12839283
31.

Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study.

Frost BM, Eksborg S, Björk O, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Lönnerholm G.

Med Pediatr Oncol. 2002 May;38(5):329-37.

PMID:
11979457
32.

How learning in the clinical area can be made effective.

Castor A.

Philipp J Nurs. 1971 Jan-Mar;40(1):17-25. No abstract available.

PMID:
5208979

Supplemental Content

Loading ...
Support Center